CAS No.641571-11-1 Pharmaceutical Intermediates
Product detail
3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline is a special compound that is a key intermediate in the synthesis of a variety of pharmaceutical products. Its unique molecular structure enables it to interact effectively with biological systems, making it valuable in the development of drugs to treat infectious diseases and certain types of cancer.
As a manufacturer and trader, we pride ourselves on producing high-quality 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline to meet the specific needs of our clients in the pharmaceutical industry.
Physical and Chemical Properties
- Appearance: White powder, stable under standard storage conditions.
- Melting point: about 120-125°C, indicating good thermal stability.
- Solubility: Soluble in organic solvents such as dimethyl sulfoxide (DMSO) and ethanol, and exhibits moderate solubility in water, enhancing its applicability in various pharmaceutical formulations.
- pH: Neutral to slightly alkaline, which is beneficial in certain chemical processes.
These properties not only enhance the reactivity of the compound but also ensure its compatibility with a wide range of other chemicals used in drug formulations.
1. Key intermediates for drug development: This compound is widely used in the synthesis of drugs and is an important component in the drug development process.
2. Chemical versatility: Ability to participate in a variety of chemical reactions, thus enabling efficient synthesis of complex molecular structures and promoting the development of innovative drugs.
3. High Purity and Quality: Our stringent quality control process ensures that 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline is of high purity, minimizing impurities that may affect the efficacy of the final drug product.
4. Stable and Reliable Performance: The chemical stability of this compound ensures that it maintains its properties over time and provides consistent results in a variety of applications.
5. Regulatory Compliance: Our manufacturing processes comply with Good Manufacturing Practices (GMP) and other international regulations, ensuring our products meet the highest safety and quality standards.
3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline is mainly used in the pharmaceutical industry and has the following uses:
- Synthesis of Active Pharmaceutical Ingredients (APIs): It is a key intermediate in the production of APIs that aid in the development of drugs in a range of therapeutic areas, including infectious diseases and oncology.
- Research and Development: Ongoing research continues to explore the potential of this compound in new drug formulations, underscoring its importance in the pharmaceutical field.
- Chemical synthesis: In addition to pharmaceuticals, this compound can also be used to synthesize other fine chemicals, demonstrating its versatility in different industries.
As a leading manufacturer and trader of 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline, we are committed to providing high-quality products that meet the evolving needs of the pharmaceutical industry. Our commitment to excellence, coupled with our integrated approach to production and trading, makes us a trusted partner for pharmaceutical companies around the world. By choosing our 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline, you can ensure that your formulation meets the highest standards of quality and efficacy, ultimately helping to improve patient outcomes.
To learn more about our products and services, please contact us today. We look forward to working with you to advance healthcare solutions.